Background
Lung cancer is the most lethal of all cancers worldwide with a dismal prognosis and 5 year survival rate of < 15%. Reports indicate that p53 alterations are the most common genetic events in lung cancer development and 50-60% of non-small cell lung cancers (NSCLC) and 90% of small cell lung cancers (SCLC) contain p53 mutations [
1]. The major reason for lung cancer incidence is tobacco smoke, which contains nicotine. There is no evidence indicating that nicotine is a carcinogen by itself [
2]; nevertheless, it has been demonstrated that nicotine promotes the growth of cancer cell populations in the lungs [
3] by stimulating cell proliferation and angiogenesis [
4,
5]. Chronic exposure to nicotine causes mitogenic stimulus and leads to the activation of growth-promoting and antiapoptotic signaling pathways such as PI3K-Akt/mTOR, NF-κB, COX-2, Bcl2, MAPKs etc [
6‐
10]. It has also been shown to induce secretion of several growth factors and upregulate the calpain family of proteins in lung cancer cells leading to the activation of Raf/MAPK/ERK pathway [
11‐
13]. Moreover, reports indicate that nicotine inhibits apoptosis induced by various stimuli including chemotherapeutic agents in lung cancer cells where survivin and XIAP are suggested to play a key role [
14].
Curcumin, a polyphenol isolated from
Curcuma longa, has been extensively investigated for its cancer chemopreventive and chemotherapeutic properties, which are attributed mainly to its antioxidant and anti-inflammatory potential [
15,
16]. Curcumin, with its potent anti-inflammatory property, is expected to exert chemopreventive effects on carcinogenesis and has been shown to modulate numerous transcription factors, protein kinases etc. that have been linked to the pathophysiology of cancer [
17]. It up-regulates several apoptosis inducing genes such as p53 and p21 [
17] and down-regulates pro-survival genes such as NF-κB, Akt, Bcl2 and Cyclin D1 [
17,
18] induced by various stimulants. This has been suggested to be the reason for its chemosensitizing efficacy [
17,
19]. Despite the bioavailability of curcumin being very low, studies indicate that even at a physiologically achievable concentration, curcumin is sufficient for its chemopreventive and chemotherapeutic activity [
20].
p53, which regulates many cellular activities including cell cycle arrest and apoptosis, is the most commonly mutated gene in human cancers [
21]. It has been well documented that absence of functional p53 in cells render them resistant to chemotherapy, and restoration of p53 lessen the tumor occurrence [
22]. One major function of p53 is to control DNA replication by inducing p21 protein, which promotes cell cycle arrest by modifying the phosphorylation of the cyclin-dependent kinases [
23], although regulation of p21 expression independent of p53 also has been reported [
24]. Activation of the p53-p21 pathway and induction of both p53 and p21 are often reported in response to DNA damaging agents including nicotine [
25].
The nuclear transcription factor NF-κB is an important survival signal which induces the expressions of diverse target genes including COX-2, Cyclin D1 and XIAP that promote cell proliferation, regulate apoptosis and stimulate invasion and metastasis [
9,
26]. Studies indicate that simultaneous inhibition of p53 and NF-κB transcriptional activities decide the fate of the cell [
27,
28]. Previous studies have also demonstrated that nicotine activates signal transduction pathways relevant to carcinogenesis through the activations of MAPK and PI3-K/Akt pathways [
6,
7].
In the present study we have tried to correlate the effect of nicotine to the p53 status of lung cancer cells, especially NSCLC cell lines of adenocarcinoma or large cell carcinoma origin. We selected these cells for our study because cigarette smoking is a major risk factor in the development of NSCLC, which accounts for 80% of all lung cancers [
14]. We report in this study that the induction of survival signals in lung cancer cells by nicotine is dependent on the p53 status of the cells and identify p53 status as an important predictor of lung cancer progression. Additionally, we have attempted in delineating the signaling cross-talk mechanism orchestrating p53-dependent regulation and expression of survival signals such as NF-κB, AP-1, Akt, Bcl2 etc., in the presence and absence of p53 expression. Our findings underscore that p53 plays an essential role in regulating survival signals, especially NF-κB, in response to nicotine. We also present data supporting our contention that curcumin down-regulates all the survival signals induced by nicotine, independent of the p53 status of the cell.
Discussion
Enormous efforts have been devoted by various research groups to identify the role of nicotine in the process of carcinogenesis by tobacco. It has been implicated as a potential risk factor in the proliferation of various cancer cells [
14,
41] and has been shown to induce enhanced tissue perfusion and angiogenesis [
5,
42]. In the present study, we have convincingly shown that nicotine induces proliferation in lung cancer cells, especially in those with impaired p53 status. It also induces an array of antiapoptotic factors in these cells. Although nicotine has been shown to induce proliferation in lung cancer cells [
4], the regulatory role of p53 on nicotine-induced proliferation has not yet been addressed. We observed a significant increase in the proliferation of lung cancer cells lacking p53. This established a ground for us to evaluate the effect of p53 in the induction of various survival signals by nicotine.
The relation between NF-κB and p53 is controversial. Conceptually, over-expression of NF-κB is linked to the development and progression of various tumors [
43] and inhibition of NF-κB function allegedly suppress tumorigenesis and leads to the regression of tumors. It has been documented that both NF-κB and p53 compete for the transcriptional co-activators [
28]. Recent reports suggest that the presence of p53 prevents NF-κB activation though, the mechanism is not clear. However, contradicting these observations, p53-induced NF-κB activation has also been reported [
44]. It has also been shown that inhibition of p53 does not inhibit NF-κB function [
27].
In our present study we observed a strong activation of NF-κB by nicotine in the p53 null H1299 cell line, while no significant activation of the same was noted in the p53 proficient A549 cells, at any of the concentrations studied. Zhang
et al[
7] have reported that pre-treatment with 100 μM nicotine up-regulate both mRNA and protein level expression of NF-κB in A549. However, supporting our observation, Moodie
et al[
45] have reported that cigarette smoke condensate, in which nicotine is one of the major components (0.3 mg/cigarette), failed to induce NF-κB in A549 cells.
A cross-talk between Akt and p53 acting as cell control machinery for switching between survival and death has been reported. Akt activation has also been reported in p53 null cells [
27]. In our study, 10
-9M - 10
-8M nicotine induced phosphorylation of Akt in H1299 cells. In contrast, a 100 fold higher concentration of nicotine was required to produce similar effects in A549. Several reports indicate interdependence between NF-κB and Akt [
26]. However, Akt independent activation of NF-κB has also been reported [
30]. In the present study we noted a strong phosphorylation of Akt by nicotine in A549 cells, although it failed to induce NF-κB in A549. This indicates that, nicotine-induced Akt phosphorylation is independent of NF-κB activation status of the cell.
No clear consensus between p53 and COX-2 exists in the literature. While some studies show that p53 up-regulates COX-2 [
46], others show that p53 down-regulates it [
47]. We observed induction of COX-2 by nicotine in A549 cells though it failed to induce NF-κB, strengthening the notion that nicotine-induced COX-2 activation in A549 cells is independent of NF-κB. Even though COX-2 is generally considered as an NF-κB dependent gene [
26], there are studies which report the activation of COX-2 independent of NF-κB [
48]. In parallel, we observed an NF-κB and p53 independent induction of Cyclin D1 by nicotine, though the expression profile was less in A549 cells. Cyclin D1 is also considered as an NF-κB dependent gene [
49] although, recent studies implicate Cyclin D1 expression through pathways independent of NF-κB [
32].
IAP family of proteins is another essential target of NF-κB [
50]. The present study as well as a previous study by Dasgupta
et al[
14], have noticed over-expression of IAPs by nicotine in A549 and H1299 cells. Of interest, this is the first study reporting the difference in the activation pattern of IAPs between both these cell lines. Bcl2 is another molecule which has a key role in regulating nicotine-induced survival signaling and has often been considered as NF-κB dependent. Interestingly, we observed Bcl2 up-regulation in both the cell lines, though the pattern of up-regulation varied between cell lines. In rapport to our observation, a novel nicotine-stimulated survival pathway that involves Bcl2 phosphorylation through MAPK pathway has been reported earlier [
10].
Nicotine also induces p53 [
25] which, often regulates the phosphorylation pattern of MAPKs [
36,
51]. On the contrary, another study reports that MAPK activation occurs only in cells with functional p53 [
52], indicating a reciprocal interaction between p53 signaling pathway and MAPK pathway. We observed a discrete difference in the phosphorylation pattern of MAPKs in both the cells. The involvement of p53 was further confirmed when the phosphorylation pattern was reversed when p53 was inactivated in A549 and introduced in H1299 cells.
AP-1 is a transcriptional regulator and phosphorylation of MAPKs leads to nuclear translocation of AP-1 [
53]. Although NF-κB and AP-1 are regulated by different mechanisms, several studies indicate that they are activated simultaneously [
54]. Nicotine induced nuclear translocation of AP-1 in both the cell lines, even though it failed to induce NF-κB in A549. However, as in the case of MAPKs, depending on the p53 status of the cell line, there was a significant change in the activation pattern of AP-1. In support of the involvement of p53 in AP1 activation, the nuclear translocation pattern of AP-1 was reversed in A549-p53DN and H1299-p53WT cells.
The ability of nicotine to enhance adherence-independent proliferation of tumor cells is well documented [
55]. We observed a marked difference in the number and size of the clones between both H1299 and A549 cells treated with nicotine, which was strongly corroborating within the concentration range of nicotine at which the survival signals are activated in both the cells, implicating a regulatory role of these survival signals on nicotine-induced enhancement of clonogenic potential. As there was a drastic reduction in the number of clones on treatment with curcumin in both the cells, it is also evident that curcumin inhibits the effect of nicotine by down-regulating these survival signals. Nicotine has a high toxicity in comparison to many other alkaloids such as cocaine and higher doses of nicotine have been reported to be lethal (0.5-1.0 mg/kg for adult humans, and 10 mg for children) [
56]. In our study, we also observed that all the survival signals induced by nicotine are abrogated at higher concentrations suggesting that there may be a balance between the pro-survival and anti-survival signals induced by this compound at different concentrations. However the exact concentration at which this switching over occurs is still unclear as we observed the cessation of various survival signals at different concentrations of nicotine.
Activation of almost all the survival signals investigated in this study is involved in the process of lung cancer progression. It has also been shown that p53 and p21 negatively regulate these survival signals [
28,
47,
23]. Induction of p53 and its downstream target p21 by nicotine has been correlated to the inhibition of cell proliferation by nicotine [
25]. We observed a strong induction of p53 as well as p21 by lower concentrations of nicotine in A549 cells which may be the reason for the absence of proliferative signals at this concentration in these cells. A strong induction of p21 was noted in response to nicotine in H1299 cells transfected with wild type p53 as well. But we did not observe any change in the expression of p53 in A549-p53DN cells. This is expected since p53 is non-functional in these cells, and hence cannot regulate the expression of p21. Similarly, no difference in expression of p21 in response to nicotine treatment was noted in H1299 cells as well as A549-p53DN cells, again confirming the role of p53 in regulating the nicotine-induced signaling events. Hence, we hypothesize that the induction of p53 and p21 by lower concentrations of nicotine in A549 cells may be one of the reasons why nicotine failed to induce these survival signals at these concentrations in A549, though further studies are required to confirm this hypothesis.
Our hypothesis that p53 is the key regulator of nicotine-induced survival signaling in lung cancer cells, was further authenticated in two more lung cancer cells with mutant p53 status. Lower concentrations of nicotine induced proliferation in these cells and pre-treatment with curcumin prevented it and, as in H1299, lower concentrations of nicotine induced NF-κB nuclear translocation in these cells too. In addition, when p53 was silenced in A549 cells by p53 siRNA, as in A549-p53 DN cells, nicotine induced a strong nuclear translocation of NF-κB, while co-transfection of these cells with WT p53 completely inhibited the same, substantiating the regulatory role of p53 in nicotine signaling.
The data obtained from our study is very significant because the average plasma level concentration of nicotine in a typical pack per day smoker is between 20-40 mg [
57]. Studies have indicated that chemotherapeutic drugs like cisplatin, which induce p53 in cells with a wild-type p53 gene can induce apoptosis in these cells while cells with mutated p53 are unaffected [
58]. Supporting this observation, Dasgupta
et al[
14] have shown that nicotine prevents the cisplatin-induced apoptosis in A549 cells with active p53. We also disclose a detrimental role of nicotine in lung cancer patients with mutant p53 status. Hence our study has proved beyond doubt that p53 has a significant role in regulating the survival signals induced by nicotine in lung cancer cells. It is also clear that curcumin down-regulates these survival signals induced by nicotine in both the cells, independent of their p53 status.
Methods
Cell lines
H1299 cell line was a gift from Prof. BB Aggarwal, MD Anderson, Houston, A549 and NCI-H522 cells were procured from NCCS, Pune, and Hop-92 was obtained from NCI, Bethesda, MD.
Chemicals
Antibodies against p53, IκBα, XIAP and cIAP-1 and phosphospecific antibodies against-IKK, p38, Akt and p42/44 were purchased from Cell Signalling (Beverly, MA) and those against p50, RelA, pJNK, COX-2 and Survivin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). G418 and pifithrin-α were procured from Calbiochem (San Diego, USA). Lipofectamine was procured from Invitrogen (Carlsbad, CA) and control siRNA and p53 siRNA were procured from Dharmacon, Inc (Chicago, IL). All other chemicals were purchased from Sigma Chemicals (St. Louis, MO).
Mode of treatment
In all combination treatments 10 μM curcumin was added 2 h before nicotine (10-8 M in H1299 and 10-6 M in A549).
MTT Assay
Proliferative/cytotoxic effect of nicotine and/or curcumin was determined by MTT assay as described earlier [
18].
[3H] Thymidine incorporation
For [
3H] thymidine incorporation assay, cells were seeded in 96 well plates and treated with required concentrations of the drugs. After 18 h of incubation, [
3H] thymidine was added (0.5 μCi/well) and further incubated for 6 h. Then the culture medium was removed, the cells were washed twice with phosphate-buffered saline (PBS), treated with 5% trichloroacetic acid, pelleted and supernatant was removed. Cells were then washed with ethanol and solubilized with 0.2N NaOH, contents of each well were mixed with 3 ml scintillation fluid and the radioactivity was counted using a liquid scintillation counter [
59]. The experiment was repeated thrice and the error bars indicate standard deviation.
Electrophoretic Mobility Shift Assay (EMSA)
To detect activation of NF-κB and AP-1, EMSA was done and visualized by a Phosphor Imager (Bio-Rad Personal FX). The specificity of the bands were confirmed by super shift [
29].
Isolation of Plasmids
The plasmids were isolated by the standard alkaline lysis method [
60].
Stable Transfection
H1299 Cells were transfected with pcDNA3-p53WT or the empty vector pcDNA3 while A549 cells were transfected with pcDNA3-p53 DN or the empty vector pcDNA3 using the calcium-phosphate transfection kit (Life Technologies, Inc.) according to manufacturer's protocol and selected using G418 (150 μg/ml) [
61].
siRNA Transfection
A549 cells were transiently transfected with control siRNA, p53 siRNA and/or WT-p53 plasmid using lipofectamine 2000 reagent according to manufactures protocol (Invitrogen).
Western blot
The total protein after treatment with nicotine and/or curcumin was electroblotted as described earlier [
18] and developed by Enhanced Chemiluminescence (Immobilon Western, Miliipore, Billerica, MA).
Clonogenic assay
The cells were treated with nicotine and/or curcumin for 72 h, as in MTT assay after which the cells were split and seeded in six well plates and clonogenic assay was done as described by Franken
et al[
62].
Statistical analysis
Statistical significance was calculated using one-way ANOVA followed by Tukey post-hoc analysis.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors read and approved the final manuscript.
VTP and VTC has equally contributed to the in vitro viability assays, transfection and NF-κB and AP-1 studies, SVB and RV contributed to the MAPK studies, AKTT carried out the clonogenic assay, BSV and PRP contributed to the detection of expression pattern of p53, IκBα and p-IKK, AB and SV contributed to the expression studies of IAPs and RJA designed and coordinated the study and drafted the manuscript.